| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |